AzTrials
AzTrials

Post Operative Nausea and VomitingPONVNCT03380754

Effects of Preoperative Carbohydrate Rich Drinks on Immediate Postoperative Outcome in Total Knee Arthroplasty

A study testing Nutricia preOp in people with Post Operative Nausea and Vomiting, run by Henry Ford Health System at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to investigate the effect of preoperative carbohydrate rich drinks on postoperative nausea and vomiting in total knee arthroplasty. This is a prospective, double blinded, randomized controlled trial. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Post Operative Nausea and Vomiting
What is being tested?
Nutricia preOp
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
150 participants
Where
1 siteUnited States
Study dates
15 Jul 2017to 1 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adult patients (>18 years of age) scheduled for elective, unilateral, primary total knee arthroplasty
  • Able to give valid consent

Who cannot join

  • Impaired gastrointestinal motility
  • On pro-motility medication
  • Pregnancy
  • HbA1c > 7.5
  • Fasting glucose >200
  • Acquired immunodeficiency
Show all 9Show fewer
  • Renal failure (creatinine > 2 mg/dL)
  • Cirrhosis
  • Severe malnutrition.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Henry Ford Hospital

    Detroit, Michigan, 48202

Other trials in United States

About this study

The aim of this study is to investigate the effect of preoperative carbohydrate rich drinks on postoperative nausea and vomiting in total knee arthroplasty. This is a prospective, double blinded, randomized controlled trial.

Read the detailed description

Postoperative nausea and vomiting (PONV) continues to pose serious challenge to orthopaedic adult reconstructive surgeons, even after recent advances in anesthesia and improvements in perioperative care. Preoperative carbohydrate loading has been well studied in non-arthroplasty surgical fields. It has been shown to benefits which include decreased postoperative catabolism and insulin resistance, dampened metabolic stress response, thus decreased postoperative pain, anxiety, nausea, and vomiting. To the investigators knowledge, there is currently no literature describing the effects of preoperative carbohydrate rich drinks (CHO) in the setting of elective total joint arthroplasty. Using a prospective, randomized, double blind, placebo controlled model, the investigators aim to determine the effect of CHO on PONV in total knee arthroplasty.

The investigators plan to include a total of 150 patients in this study. All the arthroplasty surgeons at HF Main Campus expect to participate. Estimating approximately 20 patients enrolled per month, enrollment would likely occur over time span of 8 months.

Patients who are scheduled for elective, primary total knee arthroplasty will be recruited and consented in preoperative clinic visit according to the inclusion and exclusion criteria as outlined. Screening and consenting will be performed by the orthopaedic surgeon, resident, physician assistant, or nurse practitioner in clinic, who will be trained for this study. Patients who elect to participate will be randomized to CHO drink (Group A), placebo drink (Group B), or traditional fasting/no drink (Group C). Randomization will occur prior to enrollment in batches of twenty. Patients and treatment team will be blinded to the assignment. Enrolled subjects will be given a kit which will include study information, instructions for participation, data collection questionnaire (included with this submission), multiple-alarm timer, and two beverage bottles (labeled Drink 1 and Drink 2) for those in Group A or B. Group C will receive the kit, but without beverage. A research assistant who is not involved in any of the subjects' care will be responsible for preparation of the kits.

Beverage in Group A will consist of a clear, non-carbonated lemon-flavored, iso-osmolar carbohydrate drink (Nutricia preOp; 12.5% carbohydrates, 50kcal/100mL, 260mOsm/kg, pH 5.0). This drink has been previously used in studies supporting Enhanced Recovery After Surgery (ERAS) Society Consensus Guidelines. Beverage in Group B will consist of the same quantity of clear, lemon flavored water (Nestle Splash Lemon; 0kcal/100mL). All beverages will be bottled in clear PET plastic IPEC tamper evident bottles. Bottles will be labeled Drink 1 (800 mL) or Drink 2 (400 mL). Neither subjects nor treatment team will be able to identify type of beverage, however each drink label will include a special code, available only to research assistant to be able to identify contents of bottle (treatment vs placebo).

During the evening before surgery (8:00-10:00 PM), subjects in Group A and B will consume Drink 1 (800 mL) of their respective drink. After midnight, nothing will be allowed by mouth, except for except for single morning dose of appropriate drink (Drink 2, 400 mL) in Group A and Group B. Subjects will be instructed to consume morning drink 3 hours prior to scheduled time of surgery, and be completely consumed at least 2 hours prior to surgery.

Remainder of perioperative care will be standardized and occur according to routine care for Henry Ford Joints Protocol. Henry Ford Main Campus Perioperative Primary Total Joints Protocol is included with this submission for reference. All patients will receive epidural for anesthesia. All patients will receive dexamethasone 10mg IV x 1 dose preoperatively. All patients will have ondansetron 4mg IV Q6 hours as needed available postoperatively. Multimodal perioperative pain management regimen will be standardize according to protocol.

Postoperatively, data points will be recorded by nurse in electronic medical record: events of nausea and vomiting, medication consumption, and pain VAS scores. These data points will be collected and separated by postop 0-4 hours, 4-12 hours, and 12-24 hours. Additionally, subjects will be reminded to fill out their questionnaire in preop, 4 hours postop, 12 hours postop, and 24 hours postop (questionnaire is included in this submission). Primary goal is to compare incidence and timing of postoperative nausea and vomiting between groups.

The drink/placebo will be supplied to the patient by the treating surgeon, physician assistant, or orthopaedic resident in clinic at the time of the last preoperative clinic visit prior to surgery. The appropriate drink will be included in a "kit" that will be given to the patient at that time. The kit will include study information, instructions for participation, the data collection questionnaire (included with this submission), a multiple-alarm timer, and two beverage bottles (labeled Drink 1 and Drink 2) for those in Group A or B. Group C will receive the same kit with all the same contents, but without a beverage.

The drinks will be mixed and bottled by the research assistant, and will be "ready to drink" upon receipt by the participant. This will be performed in batches of 20 to prevent any shelf-life errors. The carbohydrate rich drink (Nutricia preOp) is purchased in powder form with included instructions on mixing. Each patient package comes with 6 powder packs. The powder will be mixed in appropriate plastic beverage container with purified drinking water. Purified water will be room temperature at time of mixing, per Nutricia instructions. Drinks will be mixed in their respective beverage container according to manufacturer instruction: Drink 1 is 800 cc (4 powder packs), and drink 2 is 400 cc (2 powder packs). This drink will therefore appear clear and similar to the placebo group. For the placebo group, the appropriate amount of Nestle Splash Lemon flavored water will be poured into the appropriate bottles. Bottles will be capped with tamper evident caps. "Ready to drink" beverages will then be included in the appropriate kits by the research assistant. The kits will then be stored in a cool place, locked, away from light, in one of the K12 clinic offices. All mixing and bottling will be performed with use of standard sanitary precautions by one person, the research assistant. The research assistant will also be responsible for labelling and coding the drinks to allow for identification of the drinks.

The questionnaire will be included in the kit, which is given to the patient at their last preoperative visit prior to surgery. The kit will also include a handheld multiple-alarm timing device, which will be used to ensure patients complete the appropriate sections of their questionnaire at the requested time points. In the preoperative holding area, the patients will simply be reminded by the staff, resident, or surgeon, to complete the "preop" portion of the questionnaire. Post-operatively, the multiple-alarm timer will be utilized to standardize timing of responses. The timer will be programmed appropriately before surgery, and will be "started" by the orthopaedic resident postoperatively once the patient is dropped off in the recovery unit following surgery. The handheld timer will be pre-programmed to sound an alarm at time points 4 hours, 12 hours, and 24 hours post surgery.

Patients themselves will be mostly responsible for ensuring they comply with the requested time points in completing the questionnaire. However, the orthopaedic floor nurses will also be educated on this study and will encourage/assist in administration of the questionnaire when needed. The nurse will collect the questionnaire once it is complete, prior to patient discharge. The nursing station will have a specific folder where each questionnaire will be placed following completion. The research assistant will check folder daily, and items will be collected.

Being tested
Nutricia preOp, Nestle Splash Lemon Flavor Water (Placebo)
Keywords
Nausea, Vomiting, Knee Arthroplasty, PONV, TKA
Medical subject headings
Vomiting, Nausea, Postoperative Nausea and Vomiting

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nutricia preOpDietary supplement

    Also called Carbohydrate rich drink

    A clear, non-carbonated lemon-flavored, iso-osmolar carbohydrate drink for preoperative surgical patients. Used in studies supporting the Enhanced Recovery After Surgery (ERAS) Society Consensus Guidelines.

  • Nestle Splash Lemon Flavor Water (Placebo)Other

    Placebo control drink. PURIFIED WATER, NATURAL FLAVORS, CITRIC ACID, SODIUM POLYPHOSPHATE, POTASSIUM SORBATE (PRESERVE FRESHNESS), POTASSIUM BENZOATE (PRESERVE FRESHNESS), SUCRALOSE, ACESULFAME POTASSIUM, CALCIUM DISODIUM EDTA, MAGNESIUM SULFATE.

Study groups in NCT03380754
Study groupRoleWhat they receive
Carbohydrate Rich DrinkExperimentalGroup A will receive the carbohydrate rich drink, Nutricia preOp. This is the intervention group.
Receives: Dietary Supplement: Nutricia preOp
Placebo DrinkPlacebo comparatorGroup B will receive placebo, Nestle Splash Lemon Flavor Water (Placebo) (similarly flavored and appearing water, however with no calorie, carbohydrate or nutritional content).
Receives: Other: Nestle Splash Lemon Flavor Water (Placebo)
No DrinkNo interventionGroup C will not receive any drink. This group will follow normal protocol.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post operative nausea

    Nausea, assess by questionnaire, 10 point scale (0 = no nausea, 10 = very nauseous, and medical record.

    Measured: 4 hours postoperatively

  2. Post operative nausea

    Nausea, assess by questionnaire, 10 point scale (0 = no nausea, 10 = very nauseous, and medical record.

    Measured: 12 hours postoperatively

  3. Post operative nausea

    Nausea, assess by questionnaire, 10 point scale (0 = no nausea, 10 = very nauseous, and medical record.

    Measured: 24 hours postoperatively

  4. Post operative vomiting

    Vomiting, assess by questionnaire, 10 point scale (0 = no vomiting, 10 = copious emesis, and medical record notes of emesis.

    Measured: 4 hours postoperatively

  5. Post operative vomiting

    Vomiting, assess by questionnaire, 10 point scale (0 = no vomiting, 10 = copious emesis, and medical record notes of emesis.

    Measured: 12 hours postoperatively

  6. Post operative vomiting

    Vomiting, assess by questionnaire, 10 point scale (0 = no vomiting, 10 = copious emesis, and medical record notes of emesis.

    Measured: 24 hours postoperatively

Secondary outcomes (5)
  1. Length of hospital stay

    Length of stay recorded in hours

    Measured: From the time of hospital admission following surgery, until the time of hospital discharge as recorded in EMR, assessed up to 1 month

  2. Post operative opiate consumption

    Morphine equivalents, opiates assessed by medical record

    Measured: From the time of surgery until the time of hospital discharge, assessed up to 72 hours postoperatively

  3. Post operative pain scores

    Pain, 10 point visual analog pain scale (0 = no pain, 10 = worst pain ever)

    Measured: From the time of surgery until the time of hospital discharge, assessed up to 72 hours postoperatively

  4. Peri operative hunger and discomfort

    Hunger and discomfort, 10 point hunger scale (0 = satiated and comfortable, 10 = very hungry and uncomfortable)

    Measured: 4 hours, 12 hours, and 24 hours postoperatively

  5. Incidence of secondary adverse events

    pulmonary aspiration, delay of surgery due to consumption of drink.

    Measured: From the time of surgery until the time of hospital discharge, assessed up to 1 month postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Dec 2017
  2. Study start15 Jul 2017
  3. Primary completion1 Aug 2019
  4. Study completion1 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospective, randomized, double blinded, placebo controlled trial
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03380754
Sponsor's protocol ID
11180
Acronym
PONV
Status last verified
Feb 2020
First submitted
31 Oct 2017
Last updated
17 Feb 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: There are currently no plans to share participant data with other researchers.

Publications

  • Kadado A, Shaw JH, Ayoola AS, Akioyamen NO, North WT, Charters MA. Effects of Preoperative Carbohydrate-rich Drinks on Immediate Postoperative Outcomes in Total Knee Arthroplasty: A Randomized Controlled Trial. J Am Acad Orthop Surg. 2022 Jun 1;30(11):e833-e841. doi: 10.5435/JAAOS-D-21-00960. Epub 2022 Mar 18.

    PubMed 35312650

Questions about this trial

What is this clinical trial studying?

A study testing Nutricia preOp in people with Post Operative Nausea and Vomiting, run by Henry Ford Health System at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post operative nausea (time frame: 4 hours postoperatively). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03380754, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in